Trio of IgA Nephropathy Drugs Proves Mettle in Interim Analyses

(MedPage Today) -- DENVER -- Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy agents and a third that was recently granted accelerated approval. First, in the RAINIER...